MTDH Human

Metadherin Human Recombinant
Cat. No.
BT26361
Source
Escherichia Coli.
Synonyms
Metadherin, Lysine-Rich CEACAM1 Co-Isolated Protein, Astrocyte Elevated Gene-1 Protein, Metastasis Adhesion Protein, Astrocyte Elevated Gene 1, 3D3/LYRIC, AEG-1, LYRIC, AEG1, LYRIC/3D3, 3D3, MTDH.
Appearance
Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Metadherin Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (Val271-Asn456) containing 196 amino acids including a 10 aa His tag at N-terminus. The total calculated molecular mass is 21.5kDa.

Product Specs

Introduction
Metadherin (MTDH) is involved in the downregulation of the SLC1A2/EAAT2 promoter activity when overexpressed. This protein activates the nuclear factor kappa-B (NF-kappa-B) transcription factor and promotes anchorage-independent growth in immortalized melanocytes and astrocytes, a crucial process in tumor cell proliferation. Additionally, MTDH contributes to lung metastasis and potentially influences bone and brain metastasis by enhancing tumor cell attachment to the target organ's endothelium. Metadherin also plays a role in inducing chemoresistance.
Description
Recombinant Human Metadherin, produced in E. coli, is a single, non-glycosylated polypeptide chain (amino acids Val271-Asn456). It comprises 196 amino acids, including a 10 amino acid His tag located at the N-terminus. The calculated molecular mass of the protein is 21.5 kDa.
Physical Appearance
The product appears as a white powder that has been filtered and lyophilized (freeze-dried).
Formulation
The MTDH protein was filtered through a 0.4 μm filter and subsequently lyophilized in a buffer solution containing 20mM Tris and 50mM NaCl at a pH of 7.5.
Solubility
To prepare a working stock solution, it is recommended to add deionized water to the lyophilized pellet, aiming for a concentration of approximately 0.5 mg/ml. Allow sufficient time for the pellet to dissolve completely. Please note that the MTDH protein is not sterile. Prior to using it in cell culture, it is essential to filter the product using an appropriate sterile filter.
Stability
The lyophilized protein should be stored at -20°C. After reconstituting the product, it is advisable to aliquot it to avoid repeated freeze-thaw cycles. The reconstituted protein exhibits stability at 4°C for a limited period; no significant changes were observed after two weeks of storage at this temperature.
Purity
The purity of the protein is greater than 90.0%, as determined by SDS-PAGE analysis.
Synonyms
Metadherin, Lysine-Rich CEACAM1 Co-Isolated Protein, Astrocyte Elevated Gene-1 Protein, Metastasis Adhesion Protein, Astrocyte Elevated Gene 1, 3D3/LYRIC, AEG-1, LYRIC, AEG1, LYRIC/3D3, 3D3, MTDH.
Source
Escherichia Coli.
Amino Acid Sequence
MKHHHHHHASVSSGLNENLT VNGGGWNEKS VKLSSQISAG EEKWNSVSPA SAGKRKAEPS AWSQDTGDAN TNGKDWGRSW SDRSIFSGIG STAEPVSQST TSDYQWDVSR NQPYIDDEWS GLNGLSSADP NSDWNAPAEE WGNWVDEERA SLLKSQEPIP DDQKVSDDDK EKGEGALPTG KSKKKKKKKK KQGEDN.

Product Science Overview

Structure and Expression

Metadherin is a type-two transmembrane protein with a molecular mass of 64-kDa . It is primarily expressed in the endoplasmic reticulum and perinuclear space . The protein contains an extracellular lung homing domain, which is implicated in breast cancer metastasis to the lung .

Role in Cancer

Metadherin is overexpressed in various cancers, including breast, prostate, liver, and esophageal cancers, while its expression is low or absent in non-malignant tissues . This differential expression suggests that Metadherin may serve as a potential tumor-associated antigen . The protein regulates multiple signaling pathways, including PI3K/Akt, NF-κB, Wnt/β-catenin, and MAPK, which collectively promote the tumorigenic and metastatic potential of transformed cells .

Therapeutic Target

Given its role in cancer progression, Metadherin has been identified as a promising therapeutic target. Studies have shown that targeting Metadherin can suppress the progression and metastasis of colorectal, lung, and breast cancers . For instance, locked nucleic acid-modified (LNA) Metadherin antisense oligonucleotides (ASOs) have been developed to effectively and specifically suppress Metadherin expression in vitro and in vivo . Treatments with these ASOs in mouse models have significantly attenuated cancer progression and metastasis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.